Renan Ozyerli, MD, MSD Turkey
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Deva, a local and rooted pharmaceutical company, has been operating in Turkey since 1958. With 3 production plants and approximately 1800 employees, Deva produces and markets drugs for human use, as well as APIs, veterinary drugs, colognes, and medical vials. It offers products in 13 diversified therapeutic areas ranging from oncology to cardiology, from respiratory system to nervous system. In addition, the company provides syrups, drops, sprays, creams, gels, suppositories, aerosol inhalers, tablets, film tablets, capsules, powder suspensions, and medical ampoules. Focusing on R&D, Deva develops innovative new forms and products of high added value at its R&D centre with a competent team of approximately 170 scientists.
With its growing international operations, Deva has around 300 licenses in many countries including EU countries such as Germany, the Netherlands, Switzerland and UK through agreements with pharmaceutical firms and distributors under the Deva brand name, as well as through license agreements; and provides contract manufacturing services. Deva Holding A.S is a subsidiary of EastPharma S.a.r.l.
Contact Details
Deva Holding AS
Halkali Merkez Mah. Press Express Avenue KÜÇÜKÇEKMECE / ISTANBUL
Tel:0 (212) 692 92 92 (PBX)
Fax:0 (212) 697 00 24
Email:The info@deva.com.tr
Website: www.deva.com.tr/
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Raphaël Esposito, director of the French Chamber of Commerce in Turkey, sheds light on issues ranging from venture partnerships to cultural specificities, while underlining Turkey’s capacity to respond to the…
Asli Özelli, newly appointed executive director of AmCham Turkey, discusses the economic landscape of Turkey and its attractiveness for American companies, in addition to highlighting her priorities in her new…
Hande Demirdere, general manager of Pierre Fabre Pharma in Turkey, sheds light on the affiliate’s impressive 93 percent growth in 2017 while highlighting where to target development opportunities in the…
Selim Giray, the recently appointed VP and general manager of GSK Turkey, provides insights into the company’s eye-catching footprint and commitment to Turkey, his ambition to integrate into the market’s…
In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent.…
Elif Aral, country manager of Pfizer Turkey, stresses that Turkey will continue to be perceived as essential and important, where healthcare is a top priority with its young but aging…
Mustafa Kemal Erol , president of the Turkish Society of Cardiology, introduces one of the oldest and largest societies in the country divulges their best collaborations with the Ministry of…
Abdi İbrahim Otsuka, the Turkish-Japanese hybrid pharmaceutical company, celebrated their five-year anniversary just last year and have ambitions to become the Number One Japanese company in Turkey. Elif Elkin, in…
Mark Dekker, general manager of Astellas in Turkey, describes the ever-increasing commitment of the company to Turkey and the recent doubling of Astellas’ portfolio in the country, while pinpointing the…
Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the…
Hakan Koçak, CEO–general manager of Koçak Farma, a company with 47 years in the pharmaceutical industry and the biggest production facility in Turkey, gives a thorough insight into Koçak Farma’s…
See our Cookie Privacy Policy Here